Association Between Antenatal Corticosteroid Administration-to-Birth Interval and Outcomes of Preterm Neonates. Issue 6 (June 2015)
- Record Type:
- Journal Article
- Title:
- Association Between Antenatal Corticosteroid Administration-to-Birth Interval and Outcomes of Preterm Neonates. Issue 6 (June 2015)
- Main Title:
- Association Between Antenatal Corticosteroid Administration-to-Birth Interval and Outcomes of Preterm Neonates
- Authors:
- Melamed, Nir
Shah, Jyotsna
Soraisham, Amuchou
Yoon, Eugene W.
Lee, Shoo K.
Shah, Prakesh S.
Murphy, Kellie E. - Abstract:
- <abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <title>OBJECTIVE:</title> <p>To assess the association between antenatal corticosteroid administration-to-birth interval and outcomes.</p> </sec> <sec> <title>METHODS:</title> <p>In this retrospective cohort study, data on singleton neonates born between 24 0/7 and 33 6/7 weeks of gestation and admitted to tertiary neonatal units in Canada during 2010–2012 were obtained from the Canadian Neonatal Network. Neonatal outcomes were compared among four groups based on the interval between antenatal corticosteroid administration and birth: no antenatal corticosteroids, partial antenatal corticosteroids (less than 24 hours before birth), antenatal corticosteroids 1–7 days before birth, and antenatal corticosteroids greater than 7 days before birth. Composite outcome was defined as any of neonatal mortality, bronchopulmonary dysplasia, grade 3–4 intraventricular hemorrhage, periventricular leukomalacia, or stage 3 or higher retinopathy.</p> </sec> <sec> <title>RESULTS:</title> <p>Of 6, 870 eligible neonates, 1, 378 (20%) received no antenatal corticosteroids; 1, 473 (21%) received partial antenatal corticosteroids; 2, 721 (40%) received antenatal corticosteroids 1–7 days before birth; and 1, 298 (19%) received antenatal corticosteroids greater than 7 days before birth. The odds of the composite adverse outcome were significantly higher in all groups compared with neonates who received antenatal corticosteroids<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <title>OBJECTIVE:</title> <p>To assess the association between antenatal corticosteroid administration-to-birth interval and outcomes.</p> </sec> <sec> <title>METHODS:</title> <p>In this retrospective cohort study, data on singleton neonates born between 24 0/7 and 33 6/7 weeks of gestation and admitted to tertiary neonatal units in Canada during 2010–2012 were obtained from the Canadian Neonatal Network. Neonatal outcomes were compared among four groups based on the interval between antenatal corticosteroid administration and birth: no antenatal corticosteroids, partial antenatal corticosteroids (less than 24 hours before birth), antenatal corticosteroids 1–7 days before birth, and antenatal corticosteroids greater than 7 days before birth. Composite outcome was defined as any of neonatal mortality, bronchopulmonary dysplasia, grade 3–4 intraventricular hemorrhage, periventricular leukomalacia, or stage 3 or higher retinopathy.</p> </sec> <sec> <title>RESULTS:</title> <p>Of 6, 870 eligible neonates, 1, 378 (20%) received no antenatal corticosteroids; 1, 473 (21%) received partial antenatal corticosteroids; 2, 721 (40%) received antenatal corticosteroids 1–7 days before birth; and 1, 298 (19%) received antenatal corticosteroids greater than 7 days before birth. The odds of the composite adverse outcome were significantly higher in all groups compared with neonates who received antenatal corticosteroids 1–7 days before birth (no antenatal corticosteroids: adjusted odds ratio [OR] 2.12, 95% confidence interval [CI] 1.69–2.65; partial antenatal corticosteroids: adjusted OR 1.48, 95% CI 1.22–1.80; and antenatal corticosteroids at greater than 7 days: adjusted OR 1.46, 95% CI 1.20–1.77). Similar findings were observed with respect to neonatal mortality (no antenatal corticosteroids: adjusted OR 2.56, 95% CI 1.83–3.59; partial antenatal corticosteroids: adjusted OR 1.59, 95% CI 1.16–2.18; and antenatal corticosteroids at greater than 7 days: adjusted OR 1.40, 95% CI 1.00–1.97).</p> </sec> <sec> <title>CONCLUSION:</title> <p>Antenatal corticosteroids had maximum benefit when given between 1 and 7 days before birth.</p> </sec> <sec> <title>LEVEL OF EVIDENCE:</title> <p>II</p> </sec> </abstract> … (more)
- Is Part Of:
- Obstetrics and gynecology. Volume 125:Issue 6(2015)
- Journal:
- Obstetrics and gynecology
- Issue:
- Volume 125:Issue 6(2015)
- Issue Display:
- Volume 125, Issue 6 (2015)
- Year:
- 2015
- Volume:
- 125
- Issue:
- 6
- Issue Sort Value:
- 2015-0125-0006-0000
- Page Start:
- Page End:
- Publication Date:
- 2015-06
- Subjects:
- Obstetrics -- Periodicals
Gynecology -- Periodicals
618 - Journal URLs:
- http://journals.lww.com/greenjournal/pages/default.aspx ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/AOG.0000000000000840 ↗
- Languages:
- English
- ISSNs:
- 0029-7844
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6208.200000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 4290.xml